Global Proton Therapy Market to Reach US$ 77 Billion by 2027, Propelled by Better Technology & Rising Prevalence of Cancer Patients
21 Feb, 2022
According to the latest report by Renub Research “Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Proton Therapy Market Size was US$ 68.1 Billion in 2021. Proton therapy is an excellent treatment alternative for numerous patients, especially those with tumors close to vital organs. Besides, for children, those most vulnerable and susceptive to the damage of conventional radiation therapy, proton therapy offers less radiation exposure while demoting side effects. In addition, proton therapy is a high-tech option for X-ray radiation. With online image guidance, a scanning beam of proton radiation advises greater precision to destroy carcinogenic cells, sparing adjacent healthy tissue with more infrequent side effects.
Factors Fuelling the Growth of the Global Proton Therapy Market:
The growth of the proton therapy market across the world is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation, and increasing cancer pervasiveness. Another outstanding growth driver is the faster uptake and access and premium pricing. Further, the Worldwide Proton Therapy Market is growing at a CAGR of 2.07% during the period 2021-2027.
The United States has the Largest Number of Proton Therapy Centres Globally:
The United States is the proton therapy industry's hub, having the highest number of proton therapy hubs globally. The United Kingdom is anticipated to launch advanced multi-room proton therapy centers owned by the NHS and Private Players in the future. Besides, the emerging countries are also escalating their demand for proton therapy in their territories as some cancer and cancer-related cases have been surging and will undoubtedly boost the growth of this market during the forecast period.
Competitive Landscape:
Companies existing in the Global Proton Therapy Market are trying to create their mark by adopting new technologies at an accelerated rate. The company has also tried to enrich its product catalogs through product developments. Also, companies have acquired small companies to resolve the potential resource gap that prevailed in their technologies and products. The major players in the Global Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta.
COVID-19 Impact on Global Proton Therapy Industry:
Despite the outbreak of COVID-19 worldwide, the proton therapy market has expanded at a constant rate. Proton radiation therapy was discontinued for a brief round period, but it was renewed for patients. In addition, to take care of the regular patient and radiation therapies patients across the world, many processes have been finalized to help the patients with therapies; as such many implementations and algorithms have been carried out to safeguard the radiation patients from COVID-19.
Market Summary:
- Countries: In our report we have covered the proton therapy market of United States, United Kingdom, Switzerland, Russia, Germany, France, Italy, Sweden, Poland, Japan, Korea, China,
- Company: We have covered the key players including IBA Proton Therapy, Varian Medical Systems, Elekta
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com